Gambogic acid identifies an isoform-specific druggable pocket in the middle domain of Hsp90β
Open Access
- 27 July 2016
- journal article
- research article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 113 (33) , 201606655-E4809
Abstract
Significance: The molecular chaperone heat-shock protein 90 (Hsp90) is a key member of the cellular proteostasis network, and as such helps to protect cells against proteotoxic stress. Cancer cells have up-regulated members of this network, including Hsp90, to promote their survival and growth. Several Hsp90 inhibitors have undergone clinical trials, but these drugs, which bind to a shared nucleotide pocket in the N-terminal domain, do not differentiate between the four Hsp90 family members [Hsp90α, Hsp90β, GRP94 (glucose-regulated protein 94 kDa), and TRAP1 (tumor necrosis receptor-associated protein 1)]. In this report, we identify a pharmacophore contained within the natural product gambogic acid that binds uniquely to a site in Hsp90β, thus identifying this compound as a prototype of a new class of isoform-specific Hsp90 inhibitors.Keywords
Funding Information
- HHS | NIH | National Cancer Institute (Z01 SC010074-12)
- HHS | National Institutes of Health (CA 133002)
- Cancer Research Coordinating Committee (CRC-15-380737)
- National Science Foundation (PHY-1427654, MCB-1214457)
- Welch Foundation (C-1792)
This publication has 66 references indexed in Scilit:
- Development of a Grp94 inhibitorJournal of the American Chemical Society, 2012
- The hERG Channel Is Dependent upon the Hsp90α Isoform for Maturation and TraffickingMolecular Pharmaceutics, 2012
- Subcellular Localization and Activity of Gambogic AcidChemBioChem, 2012
- Molecular chaperones in protein folding and proteostasisNature, 2011
- Elucidation of the Hsp90 C-Terminal Inhibitor Binding SiteACS Chemical Biology, 2011
- Gambogic Acid, a Natural Product Inhibitor of Hsp90Journal of Natural Products, 2011
- Chemistry and Biology of the Caged Garcinia XanthonesChemistry – A European Journal, 2010
- Evaluation of the pharmacophoric motif of the caged Garcinia xanthonesOrganic & Biomolecular Chemistry, 2009
- Characterization of a novel novobiocin analogue as a putative C‐terminal inhibitor of heat shock protein 90 in prostate cancer cellsThe Prostate, 2009
- SNX2112, a Synthetic Heat Shock Protein 90 Inhibitor, Has Potent Antitumor Activity against HER Kinase–Dependent CancersClinical Cancer Research, 2008